您的位置：
首页
>
农业专利
>
详情页
N-ACYL- (3-SUBSTITUTED) - (8-SUBSTITUTED) -5,6-DIHYDRO- [1,2,4] TRIAZOL [4,3-A] PYRAZINES AS SELELTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, PROGRESS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS
- 专利权人:
- OGEDA S.A.
- 发明人:
- DUTHEUIL, Guillaume,FRASER, Graeme,HOVEYDA, Hamid
- 申请号：
- DK14713844
- 公开号：
- DK2948455T3
- 申请日:
- 2014.03.28
- 申请国别(地区):
- DK
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to novel compounds of Formula I and their use in therapeutic treatments.
- 来源网站：
- 中国工程科技知识中心
- 来源网址：
- http://www.ckcest.cn/home/
相关专利
- n-acyl- (3-substituted) - (8-substituted) -5,6-dihydro- [1,2,4] triazol [4,3a] pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor mediated disorders
- N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders
- Novel N-acyl-(3-substituted)-5,6, 7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders
- NOVEL N ACYL (3 SUBSTITUTED) (8 SUBSTITUTED) 5 6 DIHYDRO [1 2 4]TRIAZOLO[4 3 A]PYRAZINES AS SELECTIVE NK 3 RECEPTOR ANTAGONISTS PHARMACEUTICAL COMPOSITION METHODS FOR USE IN NK 3 RECEPTOR MEDIATED DISORDERS
- NOVEL N-ACYL-(3-SUBSTITUTED)-(8-SUBSTITUTED)-5,6-DIHYDRO- [1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR-MEDIATED DISORDERS
